The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants

Neuroendocrinology Letters

Volumn 25, Issue 5, 2004, Pages 340-348

  Pra casko, Ján ^a   Horácek, Jirí ^a   Záleský, Richard ^a   Kopecek, Miloslav ^a   Novák, Tomáš ^a   Pašková, Beata ^a   Škrdlantová, Lucie ^a   Belohlávek, Otakar ^b   Höschl, Cyril ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Antidepressants; Brain metabolism; Cognitive behavioral therapy; Neuroimaging; Panic disorder; PET

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUORODEOXYGLUCOSE F 18; SERTRALINE; VENLAFAXINE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR THERAPY; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; INSULA; LEFT HEMISPHERE; LIMBIC CORTEX; MALE; MENTAL DISEASE; PANIC; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REST; RIGHT HEMISPHERE; SCORING SYSTEM; STATISTICAL PARAMETERS; SUBICULUM; TEMPORAL CORTEX; THINKING;

EID: 10344260653     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Watkins GL, et al. Remembering the past: Two facets of episodic memory explored with positron emission tomography. Am J Psychiatry. 1995; 152 1576-1585.
2. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987; 44:211-218.
3. Bisaga A, Katz JL, Antonini A, Wright E, Margouleff C, Gorman JM, et al. Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry. 1998; 155:1178-1183.
4. Boshuisen ML, Ter Horst GJ, Paans AMJ, Reinders AATS, den Boer JA. rCBT differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol Psychiatry. 2002; 52:126-135.
5. Bremner DJ, Innis RB, White T, Masahiro F, Silbersweig D, Goddard AW, et al. SPECT [I-123] Iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry. 2000; 47 96-106.
6. Coplan JD, Lydiard RB. Brain circuits in panic disorder. Biol Psychiatry. 1998; 44:1264-1276.
7. De Cristofaro MT, Sessarego A, Pupi A, Bionti F, Faravelli C. Brain perfusion abnormalities in drug-naïve, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry. 1993; 33:505-512.
8. Goddard AW, Charney DS. Toward an integrated neurobiology of panic disorder. J Clin Psychiatry. 1997; 58 (suppl 2):4-11.
9. Gorman JM, Liebowitz MR, Fyer AJ, Stein J. A neuroanatomical hypothesis for panic disorder. Am J Psychiatry. 1989; 146(2): 148-61.
10. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000; 157 493-505.
11. Gorman J, Shear K, Cowley D, Cross DC, March J, Roth W, et al. Practice guideline for the treatment of patients with panic disorder. In: American Psychiatric Association: Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2002; 635-696.
12. Grove G, Coplan JD, Hollander E. The neuroanatomy of 5-HT dysregulation and panic disorder. J Neuropsychiatry Clin Neurosci. 1997; 9:198-207.
13. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32:50-55.
14. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6:278-296.
15. Hansen ES, Hasselbalch S, Law I, Bolwig TG. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: A PET study. Int J Neuropsychopharmacol. 2002; 5:1-10.
16. Kimbrell TA, George MS, Parekh PI, Ketter TA, Podell DM, Danielson AL, et al. Regional brain activity during transient self-induced anxiety and anger in healthy adults. Biol Psychiatry. 1999; 46:454-465.
17. Kuikka JT, Pitkanen A, Lepota U et al. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nucl Med Commun. 1995; 16:273-280.
18. Lecrubier Y, Sheehan DV, WeilLer E, et al. The MINI-international neuropsychiatric interview (M.I.N.I.): a short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997; 12:224-231.
19. A -benzodiazepine receptor binding in panic disorder. Arch Gen Psychiatry. 1998; 55:715-720.
20. Marangell LB, Ketter TA, George MS, Pazzaglia PJ, Callahan AM, Parekh P, et al. Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am J Psychiatry. 1997; 154:224-230.
21. Mayberg HS,Silva JA,Brannan SK,Tekell JL. The functional neuroanatomy of the placebo effect.Am J Psychiatry. 2002; 159: 728-738.
22. Nordhal TE, Semple WE, Gross M, Mellman TA, Stein MB, Goyer P, et al. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology. 1990; 3:261-272.
23. Nordhal TE, Stein MB, Benkelfat Ch, Semple WE, Andreason P, Zametkin A, et al. Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorder. Biol Psychiatry. 1998; 44:998-1006.
24. Oei TPS, Llamas M, Evans L. Does concurrent drug intake affect the long-term outcome of group cognitive-behavioral therapy in panic patients with or without agoraphobia? Behav Res Ther. 1997; 35 851-857.
25. Otto MW, Pollack MH, Maki KM. Empirically supported treatments for panic disorder: Costs, benefits, and stepped care. J Consult Chn Psychology. 2000; 68:556-563.
26. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, et al. [(18)F] FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry. 1995; 166:244-250.
27. 18FDG PET uptake and severity of symptomatology in panic disorder. Psychiatrie. 2003; 7(3):6-9.
28. Reiman EM, Raichle ME, Butler FK, Herscovitch P, Robins E. A focal brain abnormality in panic disorder, a severe form of anxiety. Nature. 1984; 310:683-685.
29. Reiman EM, Raichle ME, Robins E, Butler FK, Herscovitch P, Fox P, et al. The application of positron emission tomography to the study of panic disorder. Am J Psychiatry. 1986; 143:469-477.
30. Reiman EM, Raichle ME, Robins E, Mintun MA, Fusselman MJ, Fox PT, et al. Neuroanatomical correlates of a lactate induced anxiety attack. Arch Gen Psychiatry. 1989; 46:493-500.
31. Reiman EM. The application of positron emission tomography to the study of normal and pathologic emotions. J Clin Psychiatry. 1997; 58(suppl 16):4-12.
32. Reiman EM, Lane RD, Ahern GL, Schwartz GE, Davidson RJ, Friston KJ et al. Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatry. 1997; 154:918-925.
33. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry. 2000; 57:174-180.
34. Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry. 2003; 160:522-532.
35. Shulman RG. Functional imaging studies: linking mind and basic neuroscience. Am J Psychiatry. 2001; 158:11-20.
36. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative Panic Disorder Severity Scale. Am J Psychiatry. 1997; 154:1571-1575.
37. Speer AM, Kimbrell TA, Wassermann EM, Repella JD, Willis MW, Herscovitsch P, et al. Opposite effects of high and low frequency rTMS on regional rain activity in depressed patients. Biol Psychiatry. 2000; 48:1133-1141.
38. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging. Stuttgart-New York: Thieme-Verlag; 1988.
39. Telch MJ, Lucas JA, Schmidt NB, Hanna HH, LaNae JT, Lucas RA. Group cognitive behavioral treatment of panic disorder. Behav Res Ter. 1993; 31:279-289.
40. Zwanger P, Minov C, Ella R, Schülle C, Baghai T, Möller H-J, et al. Transcranial magnetic stimulation for panic. Am J Psychiatry. 2002; 159:315-316.